About Thioredoxin-related transmembrane protein 2
Thioredoxin-related transmembrane protein 2 (TMX2) is a protein
from Homo sapiens identified by UniProt accession
Q9Y320, 296 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Thioredoxin-related transmembrane protein 2 |
| UniProt accession | Q9Y320 |
| Gene | TMX2 |
| Organism | Homo sapiens |
| Length | 296 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity · score 0.76
- neurodegenerative disease · score 0.29
- Abnormality of the nervous system · score 0.27
- genetic disorder · score 0.19
- schizophrenia · score 0.13
- heel bone mineral density · score 0.11
- systolic blood pressure · score 0.11
- neuroticism measurement · score 0.10
- self reported educational attainment · score 0.10
- mean corpuscular hemoglobin · score 0.10
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y320-F1 | alphafold | PREDICTED | 85.83 | — |
Amino-acid sequence (296 residues)
MAVLAPLIAL VYSVPRLSRW LAQPYYLLSA LLSAAFLLVR KLPPLCHGLP TQREDGNPCD FDWREVEILM FLSAIVMMKN RRSITVEQHI GNIFMFSKVA NTILFFRLDI RMGLLYITLC IVFLMTCKPP LYMGPEYIKY FNDKTIDEEL ERDKRVTWIV EFFANWSNDC QSFAPIYADL SLKYNCTGLN FGKVDVGRYT DVSTRYKVST SPLTKQLPTL ILFQGGKEAM RRPQIDKKGR AVSWTFSEEN VIREFNLNEL YQRAKKLSKA GDNIPEEQPV ASTPTTVSDG ENKKDK
Explore Thioredoxin-related transmembrane protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets